“This is good news in the fight against cancer. With the launch of this new national resource, anyone can freely access raw genomic and clinical data for 12,000 patients — with more records to follow. Increasing the pool of researchers who can access data and decreasing the time it takes for them to review and find new patterns in that data is critical to speeding up development of lifesaving treatments for patients,” said Mr. Biden.
The GDC will be managed by the University of Chicago Center for Data Intensive Science in collaboration with the Ontario Institute of Cancer Research, under contract with the NCI. Researchers utilizing the tool will be able to integrate genetic and clinical data in order to facilitate more effective and expedited cancer treatments.
NCI Acting Director Douglas Lowy, MD, said, “Importantly, the explanatory power of data in the GDC will grow over time as data from more patients are included, and ultimately the GDC will accelerate our efforts in precision medicine.”
More articles on quality:
Experimental lung cancer treatment shows promise in clinical trial
Children’s hospitals push to improve sleep for patients
Prevention key to reducing racial disparities among stroke victims, study suggests
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
